SymBio Pharmaceuticals Limited [4582.T]
TOKYO, Jul 01 (Pulse News Wire) – SymBio Pharmaceuticals Limited (4582.T) reported the monthly exercise status of its 58th and 66th warrants for June 2026. The 58th warrant was issued to CVI Investments, Inc.
On June 01, 2022, while the 66th warrant was issued to EVO FUND on August 12, 2025. During June, 550 units of the 66th warrant were exercised, representing a 0.05% ratio against the total issuance of 200,000 units. No exercises occurred for the 58th warrant during the same period.
As of the end of June, there were 20,000 unexercised units of the 58th warrant remaining out of a total issuance of 20,000 units. Detailed information on these warrants can be found in previous disclosures dated May 16, 2022, and July 22, 2025. Additionally, due to contractual agreements, the exercise of the 67th warrant issued to EVO FUND on August 12, 2025, remains restricted until August 13, 2027, leading to the omission of its monthly exercise status report.
🟢 Confidence: High AI-translated content.